Hormonal control of SBP in human hepatoma cells.
Since it is currently believed that the biosynthesis of human sex steroid binding plasma protein (SBP) takes place in the liver, the secretion of this protein and its hormonal control were studied in a human hepatoma cell line. The human hepatoma-derived cell line, Hep G2, and a clone, H5A, isolated from Hep G2, were both found to secrete SBP-like protein. This protein had the same dihydrotestosterone binding parameters as plasma SBP, with a Kd ranging from 0.3 to 1 nM at 4 degrees C, and it cross-reacted with a monospecific goat anti-human SBP antiserum. In a chemically defined medium, SBP-like protein secretion was stimulated approx 2-fold by estradiol (1 microM) whereas a smaller concentration of estrogen (100 nM) has only a slight effect. A combined incubation with estradiol (100 nM) and triiodothyronine (10 nM) increased SBP-like protein secretion more than estradiol (1 microM) alone. In response to dexamethasone (100 nM) or tamoxifen (100 nM) treatment, a 3-fold increase is obtained. Therefore, these human parenchymal cells should provide a potent material for investigation of the hormonal regulation of SBP gene.
D006528:Carcinoma, Hepatocellular / Q000032:analysis* / Q000378:metabolism; D002460:Cell Line; D003907:Dexamethasone / Q000494:pharmacology; D013196:Dihydrotestosterone / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004958:Estradiol / Q000494:pharmacology; D006728:Hormones / Q000494:pharmacology*; D006801:Humans; D008113:Liver Neoplasms / Q000032:analysis* / Q000378:metabolism; D012738:Sex Hormone-Binding Globulin / Q000032:analysis* / Q000378:metabolism; D013629:Tamoxifen / Q000494:pharmacology; D014284:Triiodothyronine / Q000494:pharmacology
D006728:Hormones; D012738:Sex Hormone-Binding Globulin; D014284:Triiodothyronine; D013196:Dihydrotestosterone; D013629:Tamoxifen; D004958:Estradiol; D003907:Dexamethasone